The Christchurch Haematology Service is a tertiary centre for
the South Island of New Zealand. Services include Bone Marrow transplantation
(both autologous and allogeneic), treatment for Haematological malignancies,
bleeding and thrombotic disorders.
Supporting specialist laboratory services include surface markers,
bone marrow processing, cytogenetic, molecular and specialist haemostasis.
The Haematology department is also supported
by the research laboratories in cellular and
The Christchurch Haematology Clinical Trials Programme functions within the Christchurch Haematology Service at the Canterbury District Health Board and consists of
Three senior research coordinators lead the trial programme with all haematologists taking responsibility for clinical research within their area of expertise.
The primary objective of the Haematology clinical trials programme is to improve the standards of care offered to our patients by participating in well designed clinical trials which can offer access to innovative treatments.
Local and International
Australasian Leukaemia and Lymphoma Group (ALLG)
New Zealand Leukaemia Study Group (NZLSG)
New Zealand Bone Marrow transplant Study Group (NZBMTSG)
Centre for International Blood and Bone Marrow Transplant research (CIBMTR)
European Group for Bone marrow transplantation (EBMT)
Australasian Bone Marrow Transplant Recipient registry (ABMTRR)
French Lymphoma Group (GELA)
National Cancer Research Institute (NCRI)
UK Medical Research Council (UK MRC)
Cancer Research UK (MRCCTU)
Aventis Merck Sharp & Dohme Sanofi Sythelaba
Bayer Norvartis Genta